Dynorphin B Detection
Dynorphin B Detection - Related Videos
09:10
Combination of Adhesive-tape-based Sampling and Fluorescence in situ Hybridization for Rapid Detection of Salmonella on Fresh Produce
0 Views •
Cited by 17 •
2010
This protocol describes a simple adhesive-tape-based approach for sampling of tomato and other fresh produce surfaces, followed by rapid whole cell detection of Salmonella using fluorescence in situ hybridization (FISH).
07:05
Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
0 Views •
Cited by 2 •
2017
Target-specific probes represent an innovative tool for analyzing molecular mechanisms, such as protein expression in various types of disease (e.g., inflammation, infection, and tumorigenesis). In this study, we describe a quantitative three-dimensional tomographic assessment of intestinal macrophage infiltration in a murine model of colitis using F4/80-specific fluorescence-mediated tomography.
10:16
Detection of Viral RNA by Fluorescence in situ Hybridization (FISH)
0 Views •
Cited by 35 •
2012
A fluorescence in situ hybridization (FISH) method was developed to visually detect viral genomic RNA using fluorescence microscopy. A probe is made with specificity to the viral RNA that can then be identified using a combination of hybridization and immunofluorescence techniques. This technique offers the advantage of identifying the localization of the viral RNA or DNA at steady-state, providing information on the control of intracellular virus trafficking events.
10:05
Colorimetric Detection of Bacteria Using Litmus Test
0 Views •
Cited by 5 •
2016
We describe a protocol for colorimetric detection of E. coli using a modified litmus test that takes advantage of an RNA-cleaving DNAzyme, urease, and magnetic beads.
09:22
Gas Chromatography (GC) with Flame-Ionization Detection
0 Views •
2023
Source: Laboratory of Dr. B. Jill Venton - University of Virginia Gas chromatography (GC) is used to separate and detect small molecular weight compounds in the gas phase. The sample is either a gas or a liquid that is vaporized in the injection port. Typically, the compounds analyzed are less than 1,000 Da, because it is difficult to vaporize larger compounds. GC is popular for environmental monitoring and industrial applications because it is very reliable and can be run nearly continuously.
FAQs
Antibody-based assays identify dynorphin B through selective binding between the antibody and the peptide. Peptide-analysis approaches first separate molecules and then recognize dynorphin B through its characteristic chemical signal. These strategies rely on different recognition principles, so the selected method determines how molecular identity is established and whether the result emphasizes immunological selectivity or peptide-specific analytical detection.
Selective recognition helps distinguish dynorphin B from other substances present in a biological sample. In antibody assays, selectivity depends on binding to the intended peptide, whereas peptide analysis uses separation and a characteristic chemical signal for recognition. This distinction matters because the reliability of qualitative or quantitative measurements depends on correctly attributing the detected signal to dynorphin B.
Measured dynorphin B depends partly on how much peptide remains intact in the sample. Concentration influences whether the assay can detect or quantify the peptide, while degradation can reduce or alter the material available for recognition. Careful sample handling and assay validation therefore support more dependable interpretation when comparing dynorphin B measurements across biological samples.
A high-level workflow begins with careful handling of the biological sample, followed by an assay that either applies selective antibody binding or separates molecules before recognizing dynorphin B through its chemical signal. The resulting measurement may be qualitative, indicating presence or detection, or quantitative, estimating abundance. Validation helps assess whether the chosen approach supports reliable interpretation.
Medical researchers can use dynorphin B measurements to examine relationships between peptide abundance and opioid receptor activity, pain biology, or stress responses. The same measurements may contribute to studies of neurological and psychiatric disease. By connecting detected peptide levels with these biological contexts, the analysis supports investigation of signaling pathways and potential disease-related biomarkers.
Results can help researchers assess whether dynorphin B abundance tracks biological processes relevant to medicine. This makes the measurement useful when evaluating biomarkers or examining therapeutic mechanisms related to opioid signaling, pain, stress, neurological disease, or psychiatric disease. Interpretation remains dependent on sample integrity and validated analytical performance, because unreliable peptide measurements can weaken biological conclusions.